1. Short title This Act may be cited as the Timely ReAuthorization of Necessary Stem-cell Programs Lends Access to Needed Therapies Act of 2019 or the TRANSPLANT Act of 2019 . 2. Reauthorization of the C.W. Bill Young Cell Transplantation Program (a) Advisory council meetings Subsection (a) of section 379 of the Public Health Service Act ( 42 U.S.C. 274k ) is amended by adding at the end the following new paragraph: (7) The Secretary shall convene the Advisory Council at least two times each calendar year. . (b) Increasing collection (1) Technical clarification Effective as if included in the enactment of Public Law 114–104 (the Stem Cell Therapeutic and Research Reauthorization Act of 2015), the amendment to section 379(d)(2)(B) of the Public Health Service Act ( 42 U.S.C. 274k(d)(2)(B) ) in section 2(a)(2) of Public Law 114–104 is amended by inserting goal of increasing collections of high quality before cord blood units, . (2) Eliminating deadwood Subparagraph (B) of section 379(d)(2) of the Public Health Service Act ( 42 U.S.C. 274k(d)(2) ) is amended by striking the second and third sentences in such subparagraph. (c) Periodic review of state of science Section 379 of the Public Health Service Act ( 42 U.S.C. 274k ) is amended by adding at the end the following new subsection: (o) Periodic review of state of science (1) Review Not less than every two years, the Secretary, in consultation with the Director of the National Institutes of Health, the Commissioner of Food and Drugs, the Administrator of the Health Resources and Services Administration, the Advisory Council, and other stakeholders, where appropriate given relevant expertise, shall conduct a review of the state of the science of using adult stem cells and birthing tissues to develop new types of therapies for patients, for the purpose of considering the potential inclusion of such new types of therapies in the Program. (2) Recommendations Not later than June 30, 2024, the Secretary shall— (A) complete the second review required by paragraph (1)